Search Results - "Malvi, D."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3

    Segmental bowel resection for colorectal endometriosis: is there a correlation between histological pattern and clinical outcomes? by Mabrouk, M., Spagnolo, E., Raimondo, D., D'Errico, A., Caprara, G., Malvi, D., Catena, F., Ferrini, G., Paradisi, R., Seracchioli, R.

    Published in Human reproduction (Oxford) (01-05-2012)
    “…BACKGROUND Laparoscopic segmental resection as a treatment for intestinal endometriosis can be supported by favorable clinical outcomes, but carries a high…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models by Ambrosini, V, Quarta, C, Zinzani, P L, Nanni, C, Fini, M, Torricelli, P, Giavaresi, G, D'Errico-Grigioni, A, Malvi, D, Franchi, R, Fanti, S

    “…Kinase inhibitors have been proposed as novel therapeutic agents in different forms of solid tumours. The Food and Drug Administration (FDA) approved the use…”
    Get full text
    Journal Article
  8. 8

    18F-FDG Small Animal PET for Early Detection of Human Anaplastic Large Cells Lymphoma Xenograft in Immunocompromised Mice by AMBROSINI, V, QUARTA, C, FANTI, S, ZINZANI, P. L, FINI, M, GIAVARESI, G, TORRICELLI, P, MALVI, D, NANNI, C, GRASSETTO, G, RUBELLO, D

    Published in Anticancer research (01-03-2008)
    “…The purpose of the present study was to assess if small animal PET is useful for serially monitoring the development of a human anaplastic large cell lymphoma…”
    Get full text
    Journal Article
  9. 9
  10. 10

    P118 LOSS OF SMAD4 EXPRESSION IN ESOPHAGEAL ADENOCARCINOMA (EAC) IS CORRELATED TO POOR SURVIVAL by Mastracci, L, Isidori, F, Bozzarelli, I, Lugaresi, M, Malvi, D, Hoefnagel, S, Rasanen, J, Soderstrom, H, D'Errico, A, Fiocca, R, Seri, M, Krishnadath, K, Bonora, E, Mattioli, S

    Published in Diseases of the esophagus (23-11-2019)
    “…Abstract Aim Our study is aimed to evaluate the impact of SMAD4 expression on the clinical outcome of therapy for esophageal adenocarcinoma (EAC). Background &…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    P105 MIRNA483-3P AND MIRNA221 DYSREGULATION AND CORRELATION WITH SURVIVAL IN ESOPHAGEAL ADENOCARCINOMA (EAC) by Isidori, F, Bozzarelli, I, Lugaresi, M, Malvi, D, Mastracci, L, Hoefnagel, S J M, Räsänen, J, Söderström, H, Raulli, G, D’Errico, A, Fiocca, R, Seri, M, Krishnadath, K K, Bonora, E, Mattioli, S

    Published in Diseases of the esophagus (23-11-2019)
    “…Abstract Aim Our study aimed to characterize miR-221 and 483-3p dysregulation and to correlate their expression with clinical outcomes in patients submitted in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    P-186OPTIMUM LYMPHADENECTOMY FOR ADENOCARCINOMA OF THE OESOPHAGUS: CUT-OFF NUMBER OF RESECTED NODES VERSUS TOTAL LYMPHADENECTOMY by Perrone, Ottorino, Ruffato, A., Mattioli, S., Lugaresi, M., D'Errico, A., Malvi, D., Aprile, M.R., Raulli, G., Frassineti, L.

    “…Objectives According to the Worldwide Oesophageal Cancer Collaboration (WECC), maximum 5-year survival is modulated by T classification: resecting a minimum of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples by Gruppioni, Elisa, Vasuri, Francesco, Fiorentino, Michelangelo, Capizzi, Elisa, Altimari, Annalisa, Pirini, Maria G, Grazi, Gian L, Malvi, Deborah, Grigioni, Walter F, D'Errico-Grigioni, Antonia

    Published in Diagnostic molecular pathology (01-12-2009)
    “…The assessment of hepatitis C virus (HCV) RNA in liver tissues is clinically relevant in cases where histology, liver function tests, and HCV serology are not…”
    Get more information
    Journal Article
  19. 19